Sunitinib Capsules
Receptor Tyrosine Kinase Inhibitor
Sunitinib Capsules
Aprazer Healthcare – Leading WHO-GMP certified manufacturer and global exporter of Sunitinib Capsules (Sutekast). High-quality, reliable, affordable medicine.
Formulation
Capsules
Standard
WHO-GMP Certified Quality
Supply Type
Global Export & Institutional Supply
WHO-GMP Certified
Global Export Ready
Quality Assured
Formulation Insights
Comprehensive Medical Overview
Sunitinib Capsules
Classification: Receptor Tyrosine Kinase Inhibitor
About Sunitinib Capsules
Sunitinib is a multi-targeted receptor tyrosine kinase inhibitor used in the treatment of gastrointestinal stromal tumors (GIST), advanced renal cell carcinoma (RCC), and progressive neuroendocrine tumors of the pancreas.
Sunitinib Capsules (Sutekast) Manufactured by Aprazer Healthcare
Sutekast is formulated and manufactured under strict WHO-GMP compliance, delivering proven bioequivalence, therapeutic efficacy, and clinical reliability globally.